These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 31249382)
41. Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review. Buoli M; Caldiroli A; Cumerlato Melter C; Serati M; de Nijs J; Altamura AC Psychiatry Clin Neurosci; 2016 Jun; 70(6):227-44. PubMed ID: 26969211 [TBL] [Abstract][Full Text] [Related]
42. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls. García-Álvarez L; Caso JR; García-Portilla MP; de la Fuente-Tomás L; González-Blanco L; Sáiz Martínez P; Leza JC; Bobes J Eur Psychiatry; 2018 Jan; 47():50-59. PubMed ID: 29102659 [TBL] [Abstract][Full Text] [Related]
43. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder. Maes M; Carvalho AF Mol Neurobiol; 2018 Dec; 55(12):8885-8903. PubMed ID: 29611101 [TBL] [Abstract][Full Text] [Related]
44. Postmortem Evidence of Brain Inflammatory Markers and Injury in Septic Patients: A Systematic Review. Barichello T; Generoso JS; Dominguini D; Córneo E; Giridharan VV; Sahrapour TA; Simões LR; Rosa MID; Petronilho F; Ritter C; Sharshar T; Dal-Pizzol F Crit Care Med; 2022 Mar; 50(3):e241-e252. PubMed ID: 34402457 [TBL] [Abstract][Full Text] [Related]
45. Neurons and glial cells in bipolar disorder: A systematic review of postmortem brain studies of cell number and size. Gigase FAJ; Snijders GJLJ; Boks MP; de Witte LD Neurosci Biobehav Rev; 2019 Aug; 103():150-162. PubMed ID: 31163205 [TBL] [Abstract][Full Text] [Related]
46. Glial-Neuronal Interaction in Synapses: A Possible Mechanism of the Pathophysiology of Bipolar Disorder. Wartchow KM; Scaini G; Quevedo J Adv Exp Med Biol; 2023; 1411():191-208. PubMed ID: 36949311 [TBL] [Abstract][Full Text] [Related]
47. Leptin in bipolar disorder: A systematic review and meta-analysis. Fernandes BS; Dash S; Jacka F; Dodd S; Carvalho AF; Köhler CA; Steiner J; da Graça Cantarelli M; Nardin P; Gonçalves CA; Berk M Eur Psychiatry; 2016 May; 35():1-7. PubMed ID: 27065008 [TBL] [Abstract][Full Text] [Related]
48. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review. Misiak B; Stańczykiewicz B; Kotowicz K; Rybakowski JK; Samochowiec J; Frydecka D Schizophr Res; 2018 Feb; 192():16-29. PubMed ID: 28416092 [TBL] [Abstract][Full Text] [Related]
49. Creativity in bipolar disorder: a systematic review. Cruz TND; Camelo EV; Nardi AE; Cheniaux E Trends Psychiatry Psychother; 2022 Dec; 44():e20210196. PubMed ID: 34374271 [TBL] [Abstract][Full Text] [Related]
50. Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. Rahman S; Li PP; Young LT; Kofman O; Kish SJ; Warsh JJ J Neurochem; 1997 Jan; 68(1):297-304. PubMed ID: 8978738 [TBL] [Abstract][Full Text] [Related]
51. C-reactive protein alterations in bipolar disorder: a meta-analysis. Dargél AA; Godin O; Kapczinski F; Kupfer DJ; Leboyer M J Clin Psychiatry; 2015 Feb; 76(2):142-50. PubMed ID: 25742201 [TBL] [Abstract][Full Text] [Related]
52. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bai YM; Su TP; Li CT; Tsai SJ; Chen MH; Tu PC; Chiou WF Bipolar Disord; 2015 May; 17(3):269-77. PubMed ID: 25257835 [TBL] [Abstract][Full Text] [Related]
53. Are medical comorbid conditions of bipolar disorder due to immune dysfunction? Rosenblat JD; McIntyre RS Acta Psychiatr Scand; 2015 Sep; 132(3):180-91. PubMed ID: 25772638 [TBL] [Abstract][Full Text] [Related]
54. Inflammatory mediators in major depression and bipolar disorder. Poletti S; Mazza MG; Benedetti F Transl Psychiatry; 2024 Jun; 14(1):247. PubMed ID: 38851764 [TBL] [Abstract][Full Text] [Related]
55. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes. Isgren A; Sellgren C; Ekman CJ; Holmén-Larsson J; Blennow K; Zetterberg H; Jakobsson J; Landén M Brain Behav Immun; 2017 Oct; 65():195-201. PubMed ID: 28483660 [TBL] [Abstract][Full Text] [Related]
57. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Kauer-Sant'Anna M; Kapczinski F; Andreazza AC; Bond DJ; Lam RW; Young LT; Yatham LN Int J Neuropsychopharmacol; 2009 May; 12(4):447-58. PubMed ID: 18771602 [TBL] [Abstract][Full Text] [Related]
58. Peripheral inflammatory markers associated with brain volume reduction in patients with bipolar I disorder. Tsai SY; Sajatovic M; Hsu JL; Chung KH; Chen PH; Huang YJ Acta Neuropsychiatr; 2022 Aug; 34(4):191-200. PubMed ID: 34924065 [TBL] [Abstract][Full Text] [Related]
59. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664 [TBL] [Abstract][Full Text] [Related]